MedPath

MEGA LIFESCIENCES (AUSTRALIA) PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

86

TGA:86

Drug Approvals

Calcivita forte Capsules (461727)

Product Name
Calcivita forte Capsules
Approval Date
Sep 2, 2024
TGA

Pumpkin Seed Tablet (455285)

Product Name
Pumpkin Seed Tablet
Approval Date
Jul 15, 2024
TGA

A.B Adult Gold Pre & Pro (452188)

Product Name
A.B Adult Gold Pre & Pro
Approval Date
Jun 14, 2024
TGA

A.B Junior Pre & Pro (452187)

Product Name
A.B Junior Pre & Pro
Approval Date
Jun 14, 2024
TGA

Femiflora (449046)

Product Name
Femiflora
Approval Date
May 20, 2024
TGA

Ashwagandha Extract 300 mg Capsules (448265)

Product Name
Ashwagandha Extract 300 mg Capsules
Approval Date
May 9, 2024
TGA

Vitamin K2 Tablet (445543)

Product Name
Vitamin K2 Tablet
Approval Date
Apr 8, 2024
TGA

Methylcobalamin tablets 500 mcg (445547)

Product Name
Methylcobalamin tablets 500 mcg
Approval Date
Apr 8, 2024
TGA

GILOBA 120 (427076)

Product Name
GILOBA 120
Approval Date
Oct 30, 2023
TGA

Mega Lifesciences Cal-D Plus (427074)

Product Name
Mega Lifesciences Cal-D Plus
Approval Date
Oct 30, 2023
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 9
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.